Floatz logo

Therapeutic Asset Ratings

19,639 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
METHOTREXATE
Congenital Amegakaryocytic Thrombocytopenia
Fred Hutchinson Cancer CenterP2BB (66)
METHOTREXATE
Diamond-Blackfan Anemia
Fred Hutchinson Cancer CenterP2BB (66)
METHOTREXATE
Hematopoietic And Lymphoid Cell Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP2BB (66)
Monomethyl Fumarate
Hematologic Diseases
University of Michigan Rogel Cancer CenterP2BB (66)
Neflamapimod
Lewy Body Dementia
EIP Pharma IncP2BB (66)
Niraparib
Stage IV Pancreatic Cancer AJCC v8
OHSU Knight Cancer InstituteP2BB (66)
Nivolumab
Gastroesophageal Adenocarcinoma
Memorial Sloan Kettering Cancer CenterP2BB (66)
Nivolumab
Refractory Mantle Cell Lymphoma
University of WashingtonP2BB (66)
Nk Cell
Acute Myeloid Leukemia
Hospital de Clinicas de Porto AlegreP2BB (66)
Olaparib
Exocrine Pancreatic Carcinoma
National Cancer Institute (NCI)P2BB (66)
Olaparib
Unresectable Pancreatic Carcinoma
National Cancer Institute (NCI)P2BB (66)
Palbociclib
Hormone Receptor Positive Tumor
Relay Therapeutics, Inc.P2BB (66)
PANITUMUMAB
Breast Cancer
National Cancer Institute (NCI)P2BB (66)
Pelareorep
Breast Cancer
Adlai Nortye Biopharma Co., Ltd.P2BB (66)
Pembrolizumab
Acute Lymphoblastic Leukemia
OHSU Knight Cancer InstituteP2BB (66)
Pembrolizumab
B-Cell Non-Hodgkin Lymphoma
Rita AssiP2BB (66)
Pembrolizumab
Diffuse Large B-Cell Lymphoma
Roswell Park Cancer InstituteP2BB (66)
Pembrolizumab
Head And Neck Carcinoma
National Cancer Institute (NCI)P2BB (66)
Pembrolizumab
Metastatic Pancreatic Adenocarcinoma
Mayo ClinicP2BB (66)
Pembrolizumab
Mycosis Fungoides
Sorrento Therapeutics, Inc.P2BB (66)
Pembrolizumab
Non-Hodgkin Lymphoma
Seda S. ToluP2BB (66)
Pembrolizumab
Malignant Pancreatic Neoplasm
Essen BiotechP2BB (66)
Pembrolizumab
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Seda S. ToluP2BB (66)
Pembrolizumab
Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified
Seda S. ToluP2BB (66)
Pembrolizumab
Urinary Bladder Neoplasm
Eli Lilly and CompanyP2BB (66)
Showing 676 to 700 of 19,639 assets
PreviousPage 28 of 786Next